BLFS Q4 2021 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$37M+153.3% YoY

Gross Profit

$7M18.4% margin

Operating Income

-$18M-48.7% margin

Net Income

-$15M-40.8% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+10.4%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$3M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$553M

Total Liabilities

$72M

Stockholders' Equity

$481M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$15M	+153.3%
Gross Profit	$7M	$8M	-13.9%
Operating Income	-$18M	-$5M	-284.0%
Net Income	-$15M	-$2M	-614.9%

Revenue Segments

Service Revenue

$3M58%

Rental Revenue

$2M42%